News

MEDIA ADVISORY CEO and co-founder Alex Rosenberg, Ph.D. joining panel discussion at November 17 event  in New York WHAT:Senior executives from Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, will participate in the Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum. The one-day event will profile public and […]

New Platform to Lower Barriers to Adoption of Single Cell RNA Sequencing. ASHG Annual Meeting, Los Angeles, CA, October 26, 2022 –  Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a new cloud analysis solution to simplify the analysis of single cell RNA sequencing (scRNA-seq). The new cloud […]

Newly released Evercode™ Whole Transcriptome v2 kits have demonstrably improved gene detection and robustness. SEATTLE, August 30, 2022 –  Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products.  With substantial gains in transcript and gene detection […]

With products now available in South Korea, partnership broadens access to single cell genomics research in Asia Seattle, WA. (June 6, 2022) – Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in Asia by providing its entire line of […]

Previously available in North America, Europe, Australia and New Zealand, partnership to further accelerate single cell genomics research in the APAC region Seattle, WA, January 18, 2022 Parse Biosciences, a company providing researchers with single-cell sequencing solutions, today announced a partnership with Research Instruments Pte Ltd to provide Parse’s Evercode Whole Transcriptome Kits (WTKs), Cell Fixation Kits […]